Takeda Pharma Sp. z o.o. secures contract for Pharmaceutical products - Medicinal product Human normal immunoglobulin Recombinant human hyaluronidase set of drug administration accessories; subcutaneous administration

Poland, Sept. 24 -- Poland based Takeda Pharma Sp. z o.o. has secured contract from UNIWERSYTECKI SZPITAL KLINICZNY W POZNANIU for Pharmaceutical products - Medicinal product Human normal immunoglobulin Recombinant human hyaluronidase set of drug administration accessories; subcutaneous administration . The value of the contract is worth 1488240 PLN .

Published by HT Digital Content Services with permission from Pivotal Sources....